NasdaqGS - Nasdaq Real Time Price USD
Denali Therapeutics Inc. (DNLI)
13.91
-0.05
(-0.36%)
As of 9:47:44 AM EDT. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
37.7
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| INDV Indivior PLC | 38 | 4 | 28 | 6 |
| CRPGF CHINA RESOURCES PHARMACEUTICAL | 38 | 7 | 21 | 10 |
| DNLI Denali Therapeutics Inc. | 38 | -- | -- | -- |
| PFGTF PFGTF | 38 | -- | -- | -- |
| OTLK Outlook Therapeutics, Inc. | 38 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 5/2025
DNLI
Category Average
N/A None Controversy Level
None 4 Severe
-- DNLI
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
ALEC Alector, Inc.
1.3850
+0.36%
CYTK Cytokinetics, Incorporated
31.25
+0.13%
RARE Ultragenyx Pharmaceutical Inc.
36.04
-0.29%
RGNX REGENXBIO Inc.
10.22
-1.26%
APLS Apellis Pharmaceuticals, Inc.
19.64
+2.61%
WVE Wave Life Sciences Ltd.
6.42
+2.72%
CRNX Crinetics Pharmaceuticals, Inc.
32.37
+1.52%
ARVN Arvinas, Inc.
7.31
-0.27%
PTCT PTC Therapeutics, Inc.
48.78
-0.10%
BBIO BridgeBio Pharma, Inc.
36.22
+2.13%